Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: Prospective randomized triple-masked trial. Part 1: Aqueous concentration of moxifloxacin

Journal of Cataract and Refractive Surgery

Volumn 34, Issue 8, 2008, Pages 1379-1382

  Vasavada, Abhay R ^a   Gajjar, Devarshi ^a   Raj, Shetal M ^a   Vasavada, Vaishali ^a   Vasavada, Viraj ^a  

^a ILADEVI CATARACT AND IOL RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; AQUEOUS HUMOR; AZA COMPOUNDS; BIOLOGICAL AVAILABILITY; CATARACT EXTRACTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; QUINOLINES; TIME FACTORS;

EID: 48949118869     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2008.04.027     Document Type: Article

References (19)

1. Ta C.N. Topical antibiotic prophylaxis in intraocular injections. Arch Ophthalmol 125 (2007) 972-974
2. Solomon R., Donnenfeld E.D., Perry H.D., Snyder R.W., Nedrud C., Stein J., and Bloom A. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 112 (2005) 466-469
3. Hariprasad S.M., Mieler W.E., Shah G.K., Blinder K.J., Apte R.S., Holekamp N.M., Thomas M.A., Chi J., and Prince R.A. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. Trans Am Ophthalmol Soc 102 (2004) 149-155. http://www.aosonline.org/xactions/2004/1545-6110_v102_p149.pdf AccessedMay 12, 2008
4. Ong-Tone L. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery. J Cataract Refract Surg 33 (2007) 59-62
5. McCulley J.P., Caudle D., Aronowicz J.D., and Shine W.E. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. Ophthalmology 113 (2006) 955-959
6. Katz H.R., Masket S., Lane S., Sall K., Orr S.C., Faulkner R.D., McCue B.A., and Dahlin D.C. Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor. Cornea 24 (2005) 955-958
7. Kim D.H., Stark W.J., O'Brien T.P., and Dick J.D. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology 112 (2005) 1992-1996
8. Bucci Jr. F.A., Amico L.M., and Evans R.E. Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery. Eye Contact Lens 34 (2008) 39-42
9. Price M.O., Quillin C., and Price Jr. F.W. Effect of gatifloxacin ophthalmic solution 0.3% on human corneal endothelial cell density and aqueous humor gatifloxacin concentration. Curr Eye Res 30 (2005) 563-567
10. Lai W.W., Chu K.O., Chan K.P., Choy K.W., Wang C.C., Tsang C.W., and Pang C.P. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy. Am J Ophthalmol 144 (2007) 315-318
11. Robertson S.M., Curtis M.A., Schlech B.A., Rusinko A., Owen G.R., Dembinska O., Liao J., and Dahlin D.C. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. Surv Ophthalmol 50 suppl 1 (2005) S32-S45
12. Leaming D.V. Practice styles and preferences of ASCRS members-2003 survey. J Cataract Refract Surg 30 (2004) 892-900
13. Mather R., Stewart J.M., Prabriputaloong T., Wong J., and McLeod S.D. The effect of cataract surgery on ocular levels of topical moxifloxacin. Am J Ophthalmol 138 (2004) 554-559
14. Bucci Jr. F.A. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification. Am J Ophthalmol 137 (2004) 308-312
15. Levine J.M., Noecker R.J., Lane L.C., Herrygers L., Nix D., and Snyder R.W. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. J Cataract Refract Surg 30 (2004) 2177-2182
16. Owen G.R., Brooks A.C., James O., and Robertson S.M. A novel in vivo rabbit model that mimics human dosing to determine the distribution of antibiotics in ocular tissues. J Ocul Pharmacol Ther 23 (2007) 335-342
17. Espiritu C.R.G., Caparas V.L., and Bolinao J.G. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J Cataract Refract Surg 33 (2007) 63-68
18. O'Brien T.P., Arshinoff S.A., and Mah F.S. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. J Cataract Refract Surg 33 (2007) 1790-1800
19. Vasavada A.R., Gajjar D., Raj S.M., Vasavada V., and Vasavada V. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 2: residual conjunctival flora. J Cataract Refract Surg 34 (2008) 1384-1389